Over 1000 copies of OpenClinica™ have been downloaded. OpenClinica™ is an open source web-based software platform that enables sponsors and investigators to manage clinical research data in multi-site studies. With proprietary competitive platforms costing in the 100’s of thousands of dollars the figure of 1000 downloads represents a milestone that affirms the demand for a low cost Open Source solution to managing clinical trials.
CAMBRIDGE, MA (PRWEB) MAY 24, 2006 -- Akaza Research is pleased to announce that over 1000 copies of OpenClinica, an Open Source Clinical trial software platform, have been downloaded since OpenClinica was made available in October 2005. Representing an early milestone for open source software in the clinical trial arena, this number of downloads affirms belief in the pent-up demand for a low cost solution to the problem of staging and managing clinical trials.
Proprietary platforms that are alternatives to OpenClinica frequently cost hundreds of thousands of dollars and carry high recurring costs. These quickly become prohibitively expensive, especially for small academic or commercial clinical trials.
Akaza Research is committed to developing affordable and extensible informatics products and services, which serve the needs of academic institutions as well as commercial entities engaged in clinical, healthcare and biomedical research.
Akaza believes greater value can be obtained by using community-developed open source software along with commercial value-added services. Open solutions such as OpenClinica enable clinical researchers to effectively address the complex challenges of data management, compliance, and interoperability in the modern clinical research and healthcare environment.
The OpenClinica platform was developed using the Java J2EE framework, with a database abstraction layer interoperable with PostgreSQL 8.x (porting to DB2 and SQL Server databases planned in forthcoming releases). OpenClinica runs on Red Hat Enterprise Linux v3.x, on top of any Servlet/JSP container that implements the Servlet 2.x and JavaServer Pages 2.x specifications from the Java Community Process. It was developed to run on Apache Jakarta Tomcat 5.x. This architecture provides a secure, robust and extensible system for managing multiple clinical research studies within a centralized repository.
OpenClinica is distributed under the GNU Lesser General
Public License (LGPL), which:
- Allows unlimited use of the OpenClinica product without incurring software licensing fees.
- Provides access to the software's source code and allows its alteration and customization.
- Enables development of customized solutions and open or proprietary components based on the core (unmodified) OpenClinica platform.
- Requires the public release of modifications and derivate works used commercially outside of the institution.
OpenClinica™ is an open source web-based software platform that enables sponsors and investigators to manage clinical research data in multi-site studies. It facilitates protocol configuration, design of case report forms, electronic data capture, and study/data management. OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a strictly standards-based, extensible, and modular platform. OpenClinica v1.0 was released in late October 2005 under the GNU Lesser General Public License (LGPL). See www.OpenClinica.org.
Akaza Research, a leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data collection and management software. Akaza is bringing Open Source Software solutions into the mainstream of the clinical research enterprise by making high quality, standards-based solutions accessible for private and public research. Akaza Research provides support, training, and consulting services to its customers worldwide. See www.akazaresearch.com.
# # #
|
